Walgreens Boots Alliance (WBA) Lowered to “Sell” at BidaskClub

BidaskClub downgraded shares of Walgreens Boots Alliance (NASDAQ:WBA) from a hold rating to a sell rating in a report published on Tuesday, April 10th.

Several other analysts have also issued reports on the company. Vetr raised Walgreens Boots Alliance from a buy rating to a strong-buy rating in a report on Tuesday, December 12th. SunTrust Banks set a $80.00 price target on Walgreens Boots Alliance and gave the company a hold rating in a report on Thursday, December 21st. Zacks Investment Research raised Walgreens Boots Alliance from a hold rating to a buy rating and set a $81.00 price target for the company in a report on Wednesday, December 27th. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the company a buy rating in a report on Wednesday, January 3rd. Finally, Evercore ISI began coverage on Walgreens Boots Alliance in a report on Thursday, January 4th. They set an outperform rating and a $80.00 price target for the company. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. Walgreens Boots Alliance has a consensus rating of Buy and a consensus price target of $83.20.

How to Become a New Pot Stock Millionaire

Shares of WBA traded down $0.28 during trading hours on Tuesday, hitting $65.94. The stock had a trading volume of 4,579,733 shares, compared to its average volume of 5,895,117. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.90 and a quick ratio of 0.45. Walgreens Boots Alliance has a 12 month low of $61.74 and a 12 month high of $87.79. The firm has a market capitalization of $63,288.10, a P/E ratio of 12.93, a PEG ratio of 1.03 and a beta of 1.16.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.55 by $0.18. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The company had revenue of $33.02 billion during the quarter, compared to analyst estimates of $32.20 billion. During the same quarter in the previous year, the company posted $1.36 earnings per share. Walgreens Boots Alliance’s revenue was up 12.1% compared to the same quarter last year. analysts expect that Walgreens Boots Alliance will post 5.95 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be given a $0.40 dividend. The ex-dividend date of this dividend is Thursday, May 17th. This represents a $1.60 annualized dividend and a dividend yield of 2.43%. Walgreens Boots Alliance’s payout ratio is 31.37%.

Institutional investors have recently made changes to their positions in the company. Zions Bancorporation grew its stake in Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after purchasing an additional 1,239 shares in the last quarter. Financial Advocates Investment Management bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at $125,000. Fieldpoint Private Securities LLC boosted its position in Walgreens Boots Alliance by 428.6% during the 4th quarter. Fieldpoint Private Securities LLC now owns 1,850 shares of the pharmacy operator’s stock valued at $134,000 after acquiring an additional 1,500 shares in the last quarter. Trustcore Financial Services LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter valued at $155,000. Finally, American Research & Management Co. boosted its position in Walgreens Boots Alliance by 271.8% during the 4th quarter. American Research & Management Co. now owns 2,231 shares of the pharmacy operator’s stock valued at $162,000 after acquiring an additional 1,631 shares in the last quarter. Institutional investors and hedge funds own 60.90% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Walgreens Boots Alliance (WBA) Lowered to “Sell” at BidaskClub” was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://ledgergazette.com/2018/04/17/walgreens-boots-alliance-wba-downgraded-by-bidaskclub-to-sell.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply